| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.04 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.083 | 0.04 |